Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1577580

This article is part of the Research TopicNovel Natural Therapies for Infectious Diseases Using Computational and Pharmacological ApproachesView all 7 articles

Mechanistic Insights into Traditional Chinese Medicine for Viral Pneumonia Treatment: Signaling Pathway Perspectives

Provisionally accepted
Shihao  ZhengShihao Zheng1*Tianyu  XueTianyu Xue1Wenying  QiWenying Qi1Size  LiSize Li1Xiaobin  ZaoXiaobin Zao1Yongan  YeYongan Ye1Peng  ZhangPeng Zhang2
  • 1Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
  • 2Dongfang hospital, Beijing, China

The final, formatted version of the article will be published soon.

Since December 2019, the World Health Organization declared COVID-19 outbreak in the World as a highly contagious respiratory disease poses a significant challenge to the world. The main symptoms of patients are cough, fever, diarrhea, etc. In addition, the COVID-19 genome has strong plasticity, and there is a risk of cross-species transmission. The use of western medicine antibiotics brings good therapeutic effects, but also accompanied by many adverse reactions of physical and mental damage. At present, TCM has achieved remarkable results in the treatment of COVID-19. In addition to enriching the cognitive theories of traditional Chinese medicine in the treatment of COVID-19, studies on the cell signal transduction mechanism of TCM in the treatment of COVID-19 have developed rapidly from the perspective of molecular biology. Through literature search, it is found that the occurrence of COVID-19 is closely related to cellular inflammatory response, immune response, apoptosis, proliferation and other physiological and pathological processes. This study systematically elucidates the molecular mechanisms by which traditional Chinese medicine treats COVID-19 by regulating key signaling pathways such as PI3K/Akt, NF-κB, JAK/STAT, and mTOR. It not only effectively alleviates COVID-19 symptoms and suppresses pulmonary inflammation but also reduces complications and drug-related adverse reactions. The integrated traditional Chinese and Western medicine model demonstrates significant synergistic effects in antiviral treatment and overall regulation. Future research should further explore the cross-mechanisms of signaling pathways, strengthen evidence-based medical validation, promote the modernization of traditional Chinese medicine, and provide safer and more effective treatment strategies for global pandemic control.

Keywords: Traditional Chinese Medicine, Viral Pneumonia, COVID-19, signaling pathway, Pharmacology

Received: 16 Feb 2025; Accepted: 13 Oct 2025.

Copyright: © 2025 Zheng, Xue, Qi, Li, Zao, Ye and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Shihao Zheng, zz94080266@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.